The following documents referenced in this chapter are adopted by reference:
- (1) American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, June 2013 (DSM-5), as amended from time to time;
- (2) American Society of Addiction Medicine, ASAM Criteria: Treatment Criteria for Addictive, Substance-Related, and Co-Occurring Conditions, Third Edition, 2013;
- (3) the Revised Clinical Institute Withdrawal Assessment for Alcohol Scale ( CIWA-Ar), originally published in the British Journal of Addiction (1989), Volume 84;
- (4) the Clinical Opiate Withdrawal Scale ( COWS), originally published in the Journal of Psychoactive Drugs, Volume 35, Number 2, April-June 2003;
- (5) International Classification of Diseases - 10th Revision, Clinical Modification (ICD-10-CM), 2016 revision, as amended from time to time;
- (6) Zero to Three: National Center for Infants, Toddlers, and Families, Diagnostic Classification of Mental Health and Developmental Disorders of Infancy and Early Childhood: Revised Edition (DC:0-3R), revised as of 2005;
- (7) 42 C.F.R. Part 8 (certification of opioid treatment programs), revised as of October 1, 2015;
- (8) United States Department of Health and Human Services, Substance Abuse and Mental Health Services Administration (SAMHSA), Federal Guidelines for Opioid Treatment Programs, HHS Publication No. (SMA) PEP15-FEDGUIDEOTP, dated March 2015.
(Eff. 10/1/2011, Register 199; am 6/16/2016, Register 218; am 4/9/2017, Register 222)